Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer

INTRODUCTION: Triple-negative breast cancer (TNBC) comprises a heterogeneous group of clinically aggressive tumors with high risk of recurrence and metastasis. Current pharmacological treatment options remain largely limited to chemotherapy. Despite promising results, the efficacy of immunotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Fokhrul, Ucar, Deniz A., Monticone, Giulia, Ran, Yong, Majumder, Samarpan, Larter, Kristina, Luu, Hanh, Wyczechowska, Dorota, Heidari, Soroor, Xu, Keli, Shanthalingam, Sudarvili, Matossian, Margarite, Xi, Yaguang, Burow, Matthew, Collins-Burow, Bridgette, Del Valle, Luis, Hicks, Chindo, Zabaleta, Jovanny, Golde, Todd, Osborne, Barbara, Miele, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612326/
https://www.ncbi.nlm.nih.gov/pubmed/37901240
http://dx.doi.org/10.3389/fimmu.2023.1244159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612326/
https://www.ncbi.nlm.nih.gov/pubmed/37901240
http://dx.doi.org/10.3389/fimmu.2023.1244159

Ejemplares similares